Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight
09. Oktober 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight The rise in research and development activities in...
Schizophrenia Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Otsuka, Boehringer Ingelheim, Merck, Sunivion, PsychoGenics, Neurocrine Biosciences, Takeda, Lyndra, Cerevel
17. Oktober 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Schizophrenia Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Otsuka, Boehringer Ingelheim,...
Global Mental Health Market is estimated to be US$ 527.44 billion by 2030 with a CAGR of 3.40% during the forecast period - By PMI
22. Juni 2022 09:51 ET
|
PMI
Covina, June 22, 2022 (GLOBE NEWSWIRE) -- Dynamic internal equilibrium that enables people to make use of their talents in accordance with the common values of society is referred to as mental...
Global Antipsychotic Drugs Market Size to Reach $26.04 Billion by 2030: Allied Market Research
07. Oktober 2021 09:16 ET
|
Allied Market Research
Portland, OR, Oct. 07, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global antipsychotic drugs market generated $12.4 billion in 2020, and is projected...